Drugmakers Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LCC will pay up to $109 million in a settlement over an alleged scheme to provide doctors with free units of its knee-injection drug Hyalgan in return for purchase of the treatment.
Sanofi will pay up to $109 million to settle allegations that it gave healthcare providers free units of its knee injection drug Hyalgan to induce them to prescribe the drug, according to the Department of Justice.
